ロード中...
Prevention of Paclitaxel-Induced Neuropathy by Formulation Approach
Chemotherapy-induced peripheral neuropathy (CIPN) is a major adverse effect of paclitaxel. Several liposome-based products have been approved and demonstrated superior efficacy and safety profiles for other drugs. The first objective of this work was to evaluate the effect of liposome formulation of...
保存先:
| 出版年: | J Control Release |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708409/ https://ncbi.nlm.nih.gov/pubmed/30981814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.04.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|